Table 3.
Utility values based on RA disease activity in the Zan-CIJD population.
| Disease activity (CDAI) | Health-related quality of life (utility score) | Range | |
|---|---|---|---|
| Remission | 0.87 | 0.6525 | 1.0875 |
| LDA | 0.72 | 0.54 | 0.90 |
| MDA | 0.57 | 0.4275 | 0.7125 |
| HDA | 0.21 | 0.1575 | 0.2625 |
| Treatment target1 | 0.77 | 0.5775 | 0.9625 |
| Not at treatment target2 | 0.45 | 0.3375 | 0.5625 |
CDAI, Clinical Disease Activity Index; LDA, low disease activity; MDA, moderate disease activity; HDA, high disease activity.
1
Patients who reached remission or low-disease activity.
2
Patients who did not reach remission or low disease activity.